Apogee Enterprises beat analyst forecasts for both sales and earnings this morning. Unfortunately, sales still barely budged, and earnings were down 22% year over year. Apogee forecasts continued ...

Apogee Enterprises had a return on equity of 24.12% and a net margin of 7.58%. The business had revenue of $341.30 million for the quarter, compared to the consensus estimate of $332.27 million.

Glassmaker Apogee Enterprises (NASDAQ: APOG) stock is getting hit hard in Tuesday-morning trading, down 16.5% through 11:11 a.m. ET despite reporting better-than-expected sales and earnings this ...

Apogee Therapeutics (Apogee) is a clinical-stage biotechnology company. It focuses on the development of differentiated biologics for the treatment of various inflammatory and immune (I&I) diseases.

The newly opened South Course at the Apogee Club is distinctly different from the club’s original offering. Last February I was introduced to the Apogee Club in Hobe Sound, Fla., which I wrote was ...

Apogee Therapeutics (Apogee) is a clinical-stage biotechnology company. It focuses on the development of differentiated biologics for the treatment of various inflammatory and immune (I&I) diseases.